A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer

NCT01268059 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
99
Enrollment
INDUSTRY
Sponsor class

Stopped In conjunction with the overall risk-benefit assessment, study was terminated prematurely due to safety concerns.

Conditions

Interventions

Sponsor

MedImmune LLC